FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Changhua site meets international regulatory standards for global medical applications
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
Annual EBITDA margin expands by 170 basis points
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Net Profit increased by 15% to Rs. 146 crores in Q4 FY25 and 19% to Rs. 660 crores in FY25
Subscribe To Our Newsletter & Stay Updated
